Pfizer CMO Steps Down, Stanford Professor to Transition into Role

Retrieved on: 2021-01-05 13:07:30

Tags for this article:

Tyrosine kinase receptors

Pfizer

ROS1

Anaplastic lymphoma kinase

Click the tags to see associated articles and topics

Pfizer CMO Steps Down, Stanford Professor to Transition into Role. View article details on hiswai:

Excerpt

After two years of helming the company's pharma operations, Chief Medical Officer Mace ... “Today is my last day as Chief Medical Officer at Pfizer. ... years at Vanderbilt University and the University of Texas Health Science Center at ...

Article found on: www.biospace.com

View Original Article